This OMZO review comes down to one question: can you trust a seller whose own pages disagree on the price? OMZO’s funnel says compounded semaglutide starts at $179 for month one. Its Terms & Conditions say that price is “currently offered at $199.” Refills run a flat $299 per month either way. And the public track record backing it all: roughly 7 Trustpilot reviews and no BBB profile as of July 2026. We score OMZO 6.9/10 (Fair) — workable flat pricing sold by an operator that has not yet earned the benefit of the doubt.

OMZO in 60 Seconds

OMZO (omzo.com) is a telehealth middleman, and its terms say so plainly: “Omzo is not a medical practice or a pharmacy.” Third-party networks of US-licensed clinicians make the prescribing decision. State-licensed compounding pharmacies — never named — fill and ship the orders.

The weight-loss menu is broad for a small player. Compounded semaglutide injections from $179-$199, oral GLP-1 tablets from $249, compounded tirzepatide from $349, and brand-name Ozempic and Zepbound at $1,299-$1,399 per month per the terms. Everything is cash-pay, with free shipping and no contract.

One thing must be said up front. The compounded semaglutide and tirzepatide OMZO sells are not FDA-approved. OMZO’s own disclosure states the FDA “has not reviewed them for safety, effectiveness, or quality” — and the FDA has publicly warned consumers about risks with unapproved GLP-1 drugs.

The OMZO Review Scorecard

Category What we found
Overall score 6.9/10 — Fair
Starting price $179 advertised; $199 per Terms & Conditions
Refill price Flat $299/mo (semaglutide), no dose-based tiers
Track record ~7 Trustpilot reviews (4 stars); no BBB profile
Refund reality Money-back marketing vs terms allowing refunds in only 2 scenarios
Coverage All 50 states claimed per terms; cash-pay only

That scorecard is the whole story in miniature. The pricing structure is genuinely simple. The paperwork behind it is genuinely murky.

OMZO Cost Breakdown (2026)

Here is OMZO’s full weight-loss price list, taken from its Terms & Conditions and site pages as of July 2026. Note how often the numbers disagree with each other.

Program First month Refills
Compounded semaglutide injection $179 advertised; $199 per terms $299/mo
Compounded tirzepatide injection $349 per terms (listed as “originally $259”) $399/mo
Oral GLP-1 tablets From $249 Not published
Brand-name Ozempic $1,299/mo per terms; “$1,999/mo” in site nav Quantities limited
Brand-name Zepbound (vials) $1,399/mo per terms —

Every compounded package bundles the telehealth consultation, prescription, medication, shipping, and ongoing support into one price. There is no membership fee, no insurance requirement, and shipping is free. That bundling is real value — several competitors charge $25-$99 extra in platform fees.

Now the math you actually pay. Month one is the bait: semaglutide jumps from $199 to $299 on refill — a 50% increase — or 67% if you signed up expecting the advertised $179. A full first year on semaglutide runs about $3,488 ($199 plus 11 refills at $299). Tirzepatide runs about $4,738 in year one ($349 plus 11 x $399) — check how that $399 refill stacks up against the market in our tirzepatide cost guide.

The one honest bright spot: no dose-based pricing tiers appear anywhere. OMZO’s funnel says semaglutide refills are “locked in at $299,” so your bill should not climb as your dose escalates. Many rivals raise prices $100+ per month as doses increase.

The $179 vs $199 Problem

Lead with the number — but which number? OMZO’s funnel and navigation advertise $179 for the first month. The Terms & Conditions say the same product was “originally priced at $179, currently offered at $199.” That is a $20 gap between the ad and the contract, and the contract wins at checkout.

It is not a one-off. The terms price brand-name Ozempic at $1,299 per month, while the site navigation lists it “starting at $1,999/mo” — a $700 spread with no explanation. Tirzepatide’s “originally $259” first month is “currently” $349, a 35% markup on its own anchor price.

A $20 discrepancy will not bankrupt anyone. But when a company cannot keep its own price straight across two of its own pages, read everything else it publishes twice.

What Customers Complain About — and What They Praise

Here is the uncomfortable truth: there is almost no customer record to analyze. As of July 2026, OMZO’s Trustpilot profile holds a 4-star rating from approximately 7 reviews. Seven. We could not locate a BBB profile for Omzo or omzo.com at all.

What little praise exists tracks the pitch: one bundled price, free shipping, and a fast pipeline — OMZO claims shipment within 48 business hours of approval. The 4-star average is technically positive. But a 7-review sample is statistically meaningless; one bad month could cut that score in half.

The noise around the brand is louder than the reviews. Most “OMZO review” articles in search results are paid newswire placements, not independent journalism. The company also runs heavy funnel marketing, including multiple celebrity-themed landing pages built around “Scott Disick private weight loss” and many near-duplicate promo pages. That is a marketing engine, not a reputation.

For scale: our ReadyRx review (scored 7.2) covers a platform with about 65 Trustpilot reviews — thin, but nearly 10x OMZO’s sample, plus third-party lab testing receipts. And our Sprout Health review (scored 6.4) shows what a bad public record actually looks like: an F BBB rating and an FDA warning letter. OMZO sits between them — not caught doing anything wrong, but barely on the record at all.

How Ordering From OMZO Works

The flow is standard asynchronous telehealth, with a few dates worth memorizing.

  1. Complete the online questionnaire. Goals, medical history, lifestyle. No video visit is required.
  2. A third-party clinician reviews it. Licensed providers from outside networks “make the final determination as to whether to prescribe.” If you are declined, you get a full refund.
  3. An unnamed pharmacy ships. OMZO says a state-licensed sterile compounding pharmacy ships within 48 business hours of approval, with delivery in 3-5 business days.
  4. Ongoing care runs through the Omzo app. Messaging with the care team is bundled into the $299-$399 monthly price.

Two written protections are real. If no clinician approves you, consultation fees are refunded in full. And if your medication has not shipped within 14 business days of ordering, the shipping policy grants a full refund. Both are stronger than what some competitors put in writing.

What This OMZO Review Found in the Fine Print

Now the parts the funnel does not mention. OMZO’s marketing pushes a “lose weight or your money back” OMZO Guarantee — but the main Terms & Conditions permit refunds in only two scenarios: medical ineligibility or billing errors. Once your medical intake is submitted, orders are non-refundable. Refund requests must be made within 28 days of payment, by email only. If you buy because of the guarantee, screenshot the guarantee page first.

The transparency gaps go deeper. The compounding pharmacies are never named, and no 503A or 503B facility designation is disclosed — the terms even state products “will not bear the Omzo name or logo.” We found no legal entity name and no physical business address in the terms, and the governing-law clause vaguely points to “the state in which Omzo operates.” There is even an internal contradiction on branded drugs: the footer says Omzo “does not sell, dispense, or ship any branded medications,” while the terms offer branded fulfillment “on a limited basis.”

None of this proves bad medicine. Compounded semaglutide has legitimate uses under FDA compounding rules, and the underlying molecules are backed by major trials — semaglutide averaged ~14.9% body-weight loss over 68 weeks in STEP 1, and tirzepatide up to ~20.9% over 72 weeks in SURMOUNT-1, both at trial doses under medical supervision. But those trials tested FDA-approved drugs. OMZO’s compounded versions are not FDA-approved, and OMZO itself makes no equivalence claims.

OMZO vs MEDVi

MEDVi (scored 7.6) is the natural comparison: same $179 first-month hook, same flat $299 semaglutide refill, same cash-pay compounded model. The difference is documentation.

Factor OMZO (6.9) MEDVi (7.6)
Semaglutide, month one $179 advertised / $199 per terms $179
Semaglutide refills $299/mo flat $299/mo flat
Tirzepatide $349, then $399/mo From $349; refills $399-$499 per third-party reports
Trustpilot ~7 reviews, 4 stars ~14,000 reviews, ~4.4 stars
BBB No profile found F rating, 662 complaints
Pharmacy partners Not named Named on site (Triad Rx, RedRock, Beaker)

Read that table honestly: neither column is clean. MEDVi names its pharmacies, publishes a real business address, and carries roughly 14,000 Trustpilot reviews at about 4.4 stars — but it also holds an F BBB rating with 662 complaints, many about auto-renewal billing. OMZO has no such complaint pile, largely because almost nobody is on record buying from it.

Our take: at identical prices, verifiable beats invisible. MEDVi’s flaws are documented and priced in; OMZO’s risks are unknowns. If neither profile sits right with you, our ranking of the best online weight loss clinics compares all 11 platforms we scored, including options with far cleaner records.

Final Verdict: Who Should Actually Buy

OMZO earns its 6.9 (Fair) on structure, not evidence. The flat $299 semaglutide refill with no dose tiers is a genuinely fair deal — that pricing shape beats plenty of higher-scoring rivals. Bundled consults, free shipping, no membership fee, and two written refund rights (non-approval and the 14-business-day shipping window) round out the case for it.

Everything else argues for waiting. A $20 ad-versus-contract price gap. A $700 Ozempic listing spread. A money-back guarantee that the actual contract quietly shrinks to two narrow scenarios. Unnamed pharmacies, an unnamed legal entity, and a reputation resting on 7 reviews.

Buy OMZO if you want flat-rate compounded GLP-1 pricing, you have read the refund terms as they are actually written, and you are comfortable being an early customer of a barely-reviewed platform. Skip it if you want named pharmacies, a verifiable corporate footprint, or any meaningful customer history — MEDVi offers the same price structure with 2,000x the review volume, and our top-ranked platforms score 8.2 and above. At $3,488 for year one, “probably fine” is not the standard. Make them prove it first.